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RESEARCH ARTICLE STEM CELLS AND REGENERATION
Regeneration of the aged thymus by a single transcription factor
Nicholas Bredenkamp*, Craig S. Nowell‡ and C. Clare Blackburn§
ABSTRACT
Thymic involution is central to the decline in immune system function
that occurs with age. By regenerating the thymus, it may therefore be
possible to improve the ability of the aged immune system to respond to
novel antigens.Recently, diminishedexpressionof the thymic epithelial
cell (TEC)-specific transcription factor Forkhead box N1 (FOXN1)
has been implicated as a component of themechanism regulating age-
related involution. The effects of upregulating FOXN1 function in the
aged thymus are, however, unknown. Here, we show that forced, TEC-
specific upregulation of FOXN1 in the fully involuted thymus of aged
mice results in robust thymus regeneration characterized by increased
thymopoiesis and increased naive T cell output. We demonstrate that
the regenerated organ closely resembles the juvenile thymus in terms
of architecture and gene expression profile, and further show that
this FOXN1-mediated regeneration stems from an enlarged TEC
compartment, rebuilt from progenitor TECs. Collectively, our data
establish that upregulation of a single transcription factor can
substantially reverse age-related thymic involution, identifying FOXN1
as a specific target for improving thymus function and, thus, immune
competence in patients. More widely, they demonstrate that organ
regeneration in an aged mammal can be directed by manipulation of a
single transcription factor, providing a provocative paradigm that may
be of broad impact for regenerative biology.
KEY WORDS: Thymic involution, FOXN1, Organ regeneration,
Mouse
INTRODUCTION
The thymus, the obligate site of T lymphocyte development (Miller,
1961), is one of the first organs to degenerate in normal healthy
individuals (Chinn et al., 2012). This process, termed ‘age-related
thymic involution’, results in decreased production of naive T cells
with age (Weng, 2006; Lynch et al., 2009; Chinn et al., 2012). This
reduced output of naive T cells severely impairs the immune
response to newly encountered antigens, making thymic involution
a major cause of the age-related decline in immune system function.
Thymic involution also results in an impaired capacity to recover
adaptive immunity following immune depletion in patients
(Holland and van den Brink, 2009; Lynch et al., 2009). The
capacity to increase thymus function would therefore be beneficial
in a wide variety of clinical settings, and consequently a number of
strategies aimed at regenerating the aged thymus are currently under
investigation (van den Brink et al., 2004; Holland and van den
Brink, 2009; Markert et al., 2009).
The epithelial component of the thymic stroma is essential for
intrathymic T cell development and undergoes a stereotypical age-
related degeneration that is strongly implicated as a cause of
age-related thymic involution (Mackall et al., 1998; Gray et al.,
2006; Williams et al., 2008). The key transcription factor FOXN1
(Nehls et al., 1996) is crucially required throughout thymic
epithelial cell (TEC) differentiation in the fetal and postnatal
thymus (Chen et al., 2009; Nowell et al., 2011) and is downregulated
with age in the thymic stroma (Ortman et al., 2002; Chen et al.,
2009; Zook et al., 2011). Forced downregulation of Foxn1 in the
perinatal thymic epithelium results in loss of thymus homeostasis
(Chen et al., 2009), while overexpression in young mice delays
thymus degeneration (Zook et al., 2011). FOXN1 is thus implicated
as one of the primary targets in age-related thymic involution.
Sex-steroid signaling is also thought to be an important regulator
of involution. However, castration-induced thymic rebound was
recently demonstrated to reflect enlargement of a thymus with an
aged phenotype rather than restoration of the functionality and
architecture of the young organ (Griffith et al., 2012). Therefore, the
clinically important question of whether the effects of established
age-related thymic involution can be reversed to drive rejuvenation
of the fully involuted, aged thymus remains unanswered.
We have developed a novel transgenic model for conditional,
inducible upregulation of FOXN1 function, and have used this to
test the outcome of upregulating FOXN1 specifically in TECs in the
fully involuted thymus. Our data establish that enhanced activity of
this single transcription factor is sufficient to regenerate the fully
involuted thymus such that its architecture, gene expression profile
and function are restored to those characteristic of the juvenile
organ. They further establish that this FOXN1-mediated thymic
regeneration stems from proliferation of progenitor TECs.
RESULTS
A transgenic model for conditional inducible Foxn1
expression
To test the hypothesis that upregulation of Foxn1 in the aged, fully
involuted thymus might reverse age-related thymic involution, we
generated a transgenicmousemodel that permits conditional, inducible
overexpression ofFoxn1, through production of a tamoxifen-inducible
form of mouse FOXN1, FOXN1ERT2 (ROSA26CAG-STOP-Foxn1ERT2-
IRES-GFP mice, referred to as R26Foxn1ER; Fig. 1A; supplementary
material Figs S1 and S2). When induced by tamoxifen, this
FOXN1ERT2 protein showed equivalent activity to native FOXN1
in a minimal responsive element reporter assay (supplementary
material Fig. S3A) previously utilized to validate the activity of
another FOXN1ER protein (Janes et al., 2004), and could induce
expression of known FOXN1 targets to levels equivalent to native
FOXN1 (supplementary material Fig. S3B). To activate expression
of this transgene specifically in TECs we crossed the R26Foxn1ERReceived 11 September 2013; Accepted 10 February 2014
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line with Foxn1Cre/+ (Cre/+) mice (Gordon et al., 2007), generating
ROSA26CAG-Foxn1ERT2-IRES-GFP/+; Foxn1Cre/+ (Cre/+;R26Foxn1ER)
mice. Most, if not all, TECs in both fetal and adult Cre/+;
R26Foxn1ER mice expressed Foxn1ER as reported by GFP
expression (Fig. 1B), with Foxn1ER mRNA highly overexpressed in
aged TECs (Fig. 1C). The tamoxifen inducibility of the FOXN1ERT2
fusion protein in TECs was confirmed by immunohistochemical
(IHC) analysis (Fig. 1D,E) and immunoblotting (supplementary
material Fig. S3C,D). In the absence of tamoxifen, no differences
between control and Cre/+;R26Foxn1ER thymi were observed
at any stage of development (shown for 12-month-old mice in
supplementarymaterial Fig. S4). Collectively, these data validated our
experimental model.
Increased FOXN1 function drives thymus regeneration in
aged mice
To determine whether overexpression of FOXN1 in TECs could
reverse established thymus involution in agedmice, we treated 12- and
24-month-old Cre/+;R26Foxn1ER mice with tamoxifen for 1 month
to induce FOXN1ERT2 activity. Controlswere provided by tamoxifen-
treatedCre/+, anduntreatedCre/+;R26Foxn1ERandCre/+ littermates.
These control groups revealed a mild and transient effect of tamoxifen
treatment on thymocyte number, but no effects on thymic architecture
or TEC subset distribution (supplementary material Fig. S4).
Tamoxifen-induced upregulation of FOXN1 activity at both 12 and
24 months of age in Cre/+;R26Foxn1ER mice resulted in an overt
increase in thymus size (Fig. 2A). Total thymocyte numbers increased
more than 2.5-fold (Fig. 2B), with a proportional increase in themajor
thymocyte populations defined by expression of the CD4 and CD8
co-receptors (CD4+CD8+ double positive,CD4+ single positive,CD8+
single positive; Fig. 2C,D). The early thymic progenitor cell (ETP; lin−
CD25−Kit+) population (Allman et al., 2003),which contains themost
immature thymocytes, declines during age-related thymus involution
(Min et al., 2006) and among ETPs, the Flt3+ fraction is considered to
contain canonical intrathymic T cell progenitors (Adolfsson et al.,
2005; Sambandamet al., 2005). This lin−CD25−Kit+Flt3+ population
was also significantly increased (Fig. 2E-G) and the CD4−CD8−
double negative (DN) thymocyte populations defined by CD44 and
CD25 (also known as interleukin 2 receptor alpha chain, IL2ra)
expression were expanded by greater than 2.5-fold relative to controls
(Fig. 2H,I).Within theDN1 population (CD25−CD44+) the number of
B cells (Lin− B220+; B220 is also known as PTPRC) was reduced by
half (Fig. 2J), suggesting increased commitment into the T cell lineage
(Koch et al., 2008). These data establish that upregulation of FOXN1
activity is sufficient to promote increased thymic function in aged
mice, as shown by expansion of all currently defined thymocyte
populations, including ETPs.
We note that the increase in thymus size reported here, of 2.7-fold
in 12-month-old mice, and 2.6-fold in 24-month-old mice after
1 month of tamoxifen treatment, corresponds well with those
reported for castration-induced or keratinocyte growth factor
(KGF)-induced rebound, which each typically result in a 2- to
3.5-fold increase in thymus size (Olsen et al., 2001; Alpdogan et al.,
2006; Min et al., 2007; Williams et al., 2008; Griffith et al., 2012).
FOXN1 upregulation restores the aged thymic epithelial
microenvironment to a pre-involution phenotype
Age-related thymic involution is defined by a stereotypical
deterioration of the thymic epithelial compartment, characterized by
reduced distinction between the cortical and medullary regions;
reduction in the number of medullary islets per thymic lobe (Griffith
et al., 2012); a decline in total TEC number and in the rate of
TEC turnover (Gray et al., 2006); a specific loss of some TEC subsets
(Chen et al., 2009), including a proportional decrease inMHCClass IIhi
Fig. 1 . Generation of a regulatable FOXN1 mouse model.
(A) Schematic of Foxn1ERT2 transgene. (B) Plots show
GFP expression reporting CAG-Foxn1ER in Cre/+,
ROSA26CAG-STOP-Foxn1ERT2-IRES-GFP/+ (STOP-Foxn1ER) and Cre/+;
R26Foxn1ER TECs at the ages shown. (C) Foxn1 expression in
EpCAM+ TECs in 18-month-old Cre/+ and Cre/+;R26Foxn1ERmice,
shown normalized to the geometric mean of three housekeeping
(3HK) genes and relative to Cre/+. (D) Images show thymi from
6-week-old mice injected with carrier-only or 3 mg tamoxifen, at
2 days post-injection, after staining with the markers shown. Scale
bar: 25 μm. (E) Images show thymi from tamoxifen-treated 12-month-
old mice of the genotypes shown, after staining with the markers
shown. Scale bar: 100 μm. Error bars, s.d. Mo, month. See also
supplementary material Fig. S1. n≥3 for all experiments.
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TECs; and reduced expression of tissue-restricted antigens (Griffith
et al., 2012). Therefore, we tested the effect of FOXN1 upregulation on
these parameters. In striking contrast to aged-matched controls, the
stromal compartment in 12- and 24-month-old tamoxifen-treated Cre/
+;R26Foxn1ER thymi showed clearly defined cortical and medullary
regions, establishing that upregulation of FOXN1 activity restored
thymic epithelial architecture to be near indistinguishable from juvenile
controls (Fig. 3A). Thymi from tamoxifen-treated 12-month-oldCre/+;
R26Foxn1ER mice also exhibited increased numbers of medullary
islets compared with age-matched controls, similar to juvenile thymi
(Fig. 3B) (Griffith et al., 2012). The number of EpCAM+ TECs
(Fig. 3C) and both number and proportion ofMHCClass IIhi TECwere
significantly increased (Fig. 3C-E). Furthermore, the ratio ofmedullary
TECs (mTECs) to cortical TECs (cTECs), which decreases with age
(Grayet al., 2006;Chenet al., 2009),was restored tonear that of ayoung
thymus (Fig. 3F,G).
We also examined TEC subset distribution. The Ulex europaeus
agglutinin-1 (UEA-1)hi mTEC subpopulation, which is proposed to
regulate medullary organization (Naquet et al., 1999), declines with age
and is also preferentially lost following premature downregulation of
Foxn1 expression in the postnatal thymus (Chen et al., 2009).
This phenotype was rescued by upregulation of FOXN1 in aged
thymi; the relativenumbersofUEA-1himTECin tamoxifen-treatedCre/
+;R26Foxn1ERmicewere similar to those of youngwild-type controls
(Fig. 3A). The autoimmune regulator AIRE plays a crucial role in
negative selection of thymocytes as it regulates expression in TECs of
a set of genes that are otherwise expressed only in specific tissues or
cell types (tissue-restricted antigens or TRAs) (Anderson et al.,
2002; Mathis and Benoist, 2009). AIRE is expressed in an mTEC
subpopulation that declines numerically with age and AIRE+
mTEC number has been linked to Foxn1 expression levels (Nowell
et al., 2011). The number of AIRE+ mTECs and the expression of Aire
mRNA was significantly increased in aged, tamoxifen-treated Cre/+;
R26Foxn1ER thymi versus controls (Fig. 3H-J; see supplementary
material Fig. S5 for gating strategy for flow cytometric analysis and
sorting of TEC subsets, and validation). The AIRE-dependent TRAs
Fig. 2. Induction of FOXN1 drives thymus regeneration in aged mice. Cre/+;R26Foxn1ER and Cre/+ mice (12 and 24 months old) were treated with
tamoxifen for 1 month as described. (A) Representative thymic lobes. Scale bar: 2 mm. (B) Total thymocyte number (12 months, n=12; 24 months, n=6).
(C) Plots show flow cytometric analysis of CD4 and CD8 staining on thymic cell preparations from 12-month-old mice of the genotypes shown after gating
on CD45+ cells. (D) Numbers of CD4+CD8+ double positive (DP) and CD4+ and CD8+ single positive (SP) thymocytes in 12-month-old mice (n=10).
Numerical fold change: DP, 2.6; CD4 SP, 3.1; CD8 SP, 2.6. (E) Gating strategy for ETPs (lin− CD25− Kit+ Flt3+) in 12-month-old mice (lin: CD4, CD8, CD3e,
TCRβ, TCRγδ, NK1.1, CD11c, CD11b, Gr-1, Ter119, B220). Filled gray area, isotype control. (F) Frequency of ETPs as a percentage of total thymus cells
(n=6). (G) Number of ETPs (n=6). (H) Analysis of double negative (DN) lin− thymocytes using CD44 and CD25. Numerical fold change: 4.1. (I) Enumeration
of DN populations (DN1, CD25−CD44+; DN2, CD25+CD44+; DN3, CD25+CD44−; DN4, CD25−CD44−; n=6). Numerical fold change: DN1, 2.6; DN2, 9.9;
DN3, 4.1; DN4, 3.3. (J) B cell proportions in the DN1 compartment. Top panel, B220 staining after gating on DN1 cells (lin−CD25−CD44+, lin without B220).
Bottom panel, average proportions of B220+ cells among DN1 (n=6). Black bars, Cre/+;R26Foxn1ER; white bars, Cre/+ controls, throughout. mo, month.
Error bars, s.d.
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Fig. 3. Induction of FOXN1 restores the epithelial microenvironment in aged thymi. Cre/+;R26Foxn1ER and littermate Cre/+ mice (12 and 24 months
old) were treated with tamoxifen for 1 month; thymi from these mice were then microdissected and processed for analysis. (A) IHC for the markers shown,
revealing cortical and medullary epithelial regions [cortex, CDR1; medulla, Keratin (K) 5 or 14 and UEA-1]. Arrowheads indicate UEA-1+ TEC clusters. Scale
bars: 100 μm. (B) Hematoxylin and Eosin stained transverse sections from 12-month-old thymi. Number of medullary islets per lobe: Cre/+, 1.9; Cre/+;
R26Foxn1ER, 3.6 (n=3, P=0.009). Scale bar: 1 mm. (C) TEC (CD45−EpCAM+) numbers, showing MHC Class IIhi (dark gray) and MHC Class IIlo (light gray)
contributions (12 months, n=6; 24 months, n=3). Fold change in EpCAM+ TECs: 12 months, 2.4; 24 months, 3.6. (D) MHC Class II profiles of TECs from
tamoxifen-treated 12-month-old mice of the genotypes shown. (E) MHC Class IIhi TECs as a proportion of total TECs (12 months, n=6; 24 months, n=3).
Fold change in MHC Class IIhi TECs: 12 months old, 4.1; 24 months old, 5.7. (F) UEA-1 profile of TECs from 12-month-old tamoxifen-treated mice of the
genotypes shown (UEA-1+ TECs are mTECs). (G) mTECs (UEA-1+, Ly51−) to cTECs (UEA-1−, Ly51+) ratio in 3- and 12-month-old mice, as determined
from flow cytometric analysis (12 months, n=5). (H) IHC of tamoxifen-treated 12-month-old thymi of the genotypes shown, showing AIRE staining in mTECs
(K5 positive). Scale bar: 50 μm. (I) Number of AIRE+ cells per mm2 of medullary area in tamoxifen-treated 3- and 12-month-old mice (12 months, n=3).
(J) RT-qPCR analysis of Aire expression in mTECs from 3- and 18- to 24-month-old tamoxifen-treated mice, normalized to the geometric mean of three
housekeeping genes (n=3). (K) TRA expression in total TECs in 12-month-old mice, shown relative to young TECs after normalization to the TEC
housekeeping gene Eva (Mpzl2) (expression level in TECs at 3 months=1; n≥3 for all genes). mo, month; MHC II, MHC Class II. Error bars, s.d.
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casein alpha (Csna; Csn1s1 – Mouse Genome Informatics), insulin 2
(Ins2), intestinal fatty acid binding protein (I-FABP; Fabp2 – Mouse
Genome Informatics), salivaryprotein1 (Spt1) and trefoil factor 3 (Tff3),
which decrease during thymus involution (Anderson et al., 2002;
Derbinski et al., 2005),were alsoupregulatedupon inductionofFOXN1
activity (Fig. 3K), establishing the functionality of the new AIRE+
mTECs. The two AIRE-independent TRAs tested, casein beta (Csnb;
Csn2 – Mouse Genome Informatics) and glutamate decarboxylase
67 (GAD67; Gad1 – Mouse Genome Informatics) (Anderson et al.,
2002), were also upregulated. Collectively, these data indicate that
thymus structure and functionwere regenerated to closely resemble their
pre-involution phenotypes in the FOXN1-regenerated aged thymus.
FOXN1 upregulation restores the expression of genes
required for TEC function
To probe further the effects of FOXN1 upregulation on the thymic
microenvironment, we next tested the effects of normal ageing and of
FOXN1 induction on a panel of genes required cell-autonomously in
TECs for TEC development or for T cell differentiation and repertoire
selection. Delta-like 4 (Dll4), chemokine (C-C motif) ligand 25
(Ccl25), kit ligand (Kitl) and chemokine (C-X-C motif) ligand 12
(Cxcl12) are putative transcriptional targets of FOXN1 that are
expressed in cTECs and are required for the early stages of T cell
development (Rodewald et al., 1997; Koch et al., 2008; Trampont
et al., 2010; Zlotoff et al., 2010; Nowell et al., 2011; Calderon and
Boehm, 2012); Cd40, Cd80, cathepsin L (Ctsl) and paired box 1
(Pax1) are expressed specifically in mTECs (Cd80), cTECs (Ctsl,
Pax1) or both (Cd40), and are required in TECs to mediate normal T
cell development (ReiserandSchneeberger, 1994;VanDenBerget al.,
1996; Wallin et al., 1996; Honey et al., 2002; Akiyama et al., 2008).
Expression of all of these genes was substantially downregulated
in aged versus young cTECs (Fig. 4A; see supplementary material
Fig. S5 for gating strategy for flow cytometric analysis and sorting of
TEC subsets, and validation), consistent with an age-related decline
in TEC functionality. Fibroblast growth factor receptor 2 isoform
IIIb (FgfR2IIIb), the receptor for fibroblast growth factors 7 and 10
(Revest et al., 2001), and the delta N isoform of transformation-
related protein 63 (p63, also known as TRP63) ΔNp63 (Candi et al.,
2007; Senoo et al., 2007) were also significantly downregulated in
aged versus young TECs (Fig. 4A; note that FgfR2IIIb expression is
restricted to cTECs), consistent with decreased TEC proliferation
with age (Gray et al., 2006).
Tamoxifen-treated Cre/+;R26Foxn1ER mice exhibited increased
expression ofDll4 in TECs, such that the relative expression level was
similar to that in TECs from 3-month-old mice (Fig. 4B,C;
supplementary material Fig. S5 and Fig. S6A). Strikingly, Dll4 was
upregulated only in cTECs (Fig. 4C), where it was predominantly
expressed in the MHC Class IIhi subset (supplementary material Fig.
S6A). Thus, although functional FOXN1was upregulated in all TECs,
FOXN1 targets maintained their expected TEC subset-specific
expression. Of note is that the expression profile for DLL4 protein on
TECs in the FOXN1-regenerated thymus is characteristic of the young
rather than the aged thymus (Fiorini et al., 2008; Koch et al., 2008).
Ccl25,Kitl,Cxcl12,Cd40,Cd80,Ctsl and Pax1were also upregulated
close to levels found in 3-month-old TECs (Fig. 4B). Increased
expression of these genes in the aged thymus in response to FOXN1
upregulation provides a mechanistic explanation for the specific
impacts observed on the early thymocyte compartment, including the
proportional drop in intrathymic B cells which probably results from
increased DLL4 expression (Hozumi et al., 2008; Koch et al., 2008).
Among signaling pathways, the Wnt pathway is reportedly most
affected in TECs by age-related thymic involution (Griffith et al.,
2012). Our analysis confirmed substantially downregulated
expression of many Wnt pathway genes in aged versus young
TECs, and extended previous findings to show that many of these
genes are differentially regulated in c- and mTECs (Fig. 4D,D0).
Strikingly, expression of most of the Wnt pathway genes analyzed
were restored to young levels in tamoxifen-treated aged Cre/+;
R26Foxn1ERTECs (Fig. 4D,D0).Again, these genesmaintained their
normal TEC subset-specific expression upon FOXN1 upregulation.
Of note is that lymphotoxin receptor β (Ltbr), interleukin 7 (Il7), v-rel
avian reticuloendotheliosis viral oncogene homolog B (Relb) and
intracellular adhesion molecule 1 (Icam1) were expressed at
equivalent levels in aged, young and tamoxifen-treated aged Cre/
+;R26Foxn1ER TECs (supplementary material Fig. S7A).
Collectively, these data establish that reduced FOXN1 expression
is the crucial factor limiting expression of a wide range of genes in
aged TECs, and provide additional evidence that the FOXN1-
regenerated thymus very closely resembles the young thymus.
FOXN1 mediates thymus regeneration by increasing
proliferation of progenitor TEC
TEC proliferation is known to decrease with age, with an
approximately threefold decrease in the proportion of proliferating
TECs from 4 weeks to 10 months of age (Gray et al., 2006), and a
link between FOXN1 and TEC proliferation has been established in
fetal thymus (Itoi et al., 2001). To determine the cellular mechanism
through which FOXN1 upregulation leads to thymus regeneration,
we therefore tested whether the increase in TEC numbers resulted
from increased TEC proliferation, using Ki67 staining. The
proportion of proliferating cells in the total TEC population
increased by twofold upon upregulation of FOXN1 function in
12-month-old mice (Fig. 4E; supplementary material Fig. S6B).
Among cTECs, proliferation was significantly increased only in the
MHC Class IIlo compartment, which contains putative progenitor
cTECs (Fig. 4F). The numbers of both MHC Class IIlo and MHC
Class IIhi cTECs increased, however, indicating that in the
regenerated thymi this MHC Class IIhi cTEC compartment was
rebuilt from a progenitor TEC pool (Fig. 4F,G). We found increased
proliferation of both MHC Class IIlo and MHC Class IIhi mTECs
(Fig. 4F); both of these mTEC compartments contain proliferating
cells in young mice (Tykocinski et al., 2008).
To investigate the molecular basis of this increased proliferation,
we analyzed expression of genes with roles in cell cycle progression
and TEC proliferation. We observed an increase in the number of
TECs expressing ΔNp63, which marks proliferative potential in
epithelial cells including TECs (Candi et al., 2007; Senoo et al.,
2007), in tamoxifen-treated aged Cre/+;R26Foxn1ER thymi versus
age-matched controls (Fig. 4A,B,H); expression of the cell cycle
regulator cyclin D1 and of Fgf2RIIIb was also upregulated
(Fig. 4A,B). Fgf2RIIIb was previously been reported to be
regulated by FOXN1 (Tsai et al., 2003). However, neither Ccnd1
nor p63 has previously been suggested to be a direct or indirect
transcriptional target of FOXN1, and these data therefore expand the
set of FOXN1-regulated targets to include these genes. As ΔNp63,
cyclin D1 and Fgf2RIIIb have all previously been shown to regulate
TEC proliferation (Robles et al., 1996; Revest et al., 2001), this
provides a mechanistic link between increased FOXN1 expression
and the expansion of TECs observed in these experiments.
Of note is that we could not detect interleukin 22 receptor (Il22r)
expression (Dudakov et al., 2012) in tamoxifen-treated Cre/+;
Foxn1ER TEC in aged mice (supplementary material Fig. S7B),
indicating that FOXN1-mediated thymus regeneration acts via an
IL22-independent mechanism.
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Fig. 4. Induction of FOXN1 elevates epithelial proliferation and gene expression. (A) mRNA expression levels of the genes shown in mTECs (m) and/or
cTECs (c) from young (3-month-old) and aged (18-month-old) wild-type mice, shown as fold-change relative to young mice after normalization to the
geometric mean of three housekeeping (3HK) genes (3 months, n=1; 18 months, n=3). (B) mRNA expression levels in TECs from tamoxifen-treated 18- to
24-month-old mice of the genotypes shown, shown as fold change relative to Cre/+ controls (gray line) after normalization to the geometric mean of 3HK
genes (n=3). (C) Top: DLL4 expression on cTECs and mTECs from tamoxifen-treated 12-month-old Cre/+;R26Foxn1ER mice. Bottom: DLL4 expression on
cTECs from tamoxifen-treated 12-month-old Cre/+ and Cre/+;R26Foxn1ER mice. (D,D0) mRNA expression levels of the genes shown in mTECs (m)
and cTECs (c) from tamoxifen-treated young (3-month-old) and aged (12-month-old) mice, shown as fold-change relative to cTECs or mTECs from young
mice after normalization to the geometric mean of 3HK. Data represent the expression levels in TECs pooled from four mice. Red asterisks indicate genes
downregulated in involution and restored upon FOXN1 upregulation. (E,F) Proportion of Ki67+ TECs in total EpCam+ TECs (E) and the major TEC
subpopulations (F) (mTECs: UEA-1+, Ly51−; cTECs: UEA-1−, Ly51+) from tamoxifen-treated 12-month-old mice of the genotypes shown (n=4).
(G) Schematic of TEC subpopulation numbers in tamoxifen-treated 12-month-old mice of the genotypes shown. hi and lo refer to MHC Class II surface
expression levels. (H) Analysis of tamoxifen-treated 12-month-old thymi showing ΔNp63 staining. Scale bar: 50 μm. Black bars, Cre/+;R26Foxn1ER;
white bars, Cre/+ controls, throughout. c, cTECs; m, mTECs; mo, month; MHC II, MHC Class II. Error bars, s.d.
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FOXN1-mediated thymus regeneration impacts the
peripheral immune system by increasing naive T cell
numbers
A crucial question is whether these changes in thymocyte numbers
translate into an altered peripheral lymphocyte pool. Age-related
thymic involution leads to a numerical and proportional decrease in
naive T cells in the peripheral pool, that is thought to be amajor factor
in the capacity of the immune system to respond to new antigenic
challenge (Goronzy and Weyand, 2005). Both CD4+ and CD8+
splenocytes from aged, tamoxifen-treated Cre/+;R26Foxn1ER mice
contained a significantly higher proportion of CD3+CD62L+CD44lo
(CD62L is also known as SELL) naive T cells (Budd et al., 1987)
than controls (Fig. 5A,B), demonstrating improved export of naive T
cells from the thymus. To specifically identify recent thymic
emigrants (RTEs), the CD45RB phenotype of CD4+ splenocytes
was analyzed (Boursalian et al., 2004). Upregulation of FOXN1-
activity in 24-month-old Cre/+;R26Foxn1ER mice resulted in a
higher proportion of CD45RBlo RTEs among naive splenic T cells
(supplementary material Fig. S8A,B), and the proportion and
numbers of RTEs in the total splenic CD4+ compartment of 12-
and 24-month-old tamoxifen-treated Cre/+;R26Foxn1ER mice were
increased by twofold versus controls by 1 month after treatment
commenced (Fig. 5C,D; supplementary material Fig. S8B). The
increase in RTEs was also evidenced by a greater than twofold
increase in T cell receptor excision (TREC) (Sempowski et al., 2002)
number in both CD4+ and CD8+ CD45RB+ naive splenocytes
(Fig. 5E; supplementary material Fig. S8C). Thus, upregulation of
FOXN1 in aged thymi resulted in an increase in the export of RTEs to
the periphery with consequent increase in the numbers and
proportions of naive T cells in the peripheral immune system.
DISCUSSION
We have shown that upregulation of a crucial regulator of TEC
differentiation, FOXN1, is sufficient to drive regeneration of the
aged thymus such that it closely resembles the juvenile, pre-
involution thymus in terms of architecture, gene expression and
functionality. This FOXN1-mediated thymus regeneration results in
improved thymic output in aged mice, with increased numbers of
naive T cells exported to peripheral lymphoid organs. Collectively,
our data demonstrate that the major impacts of age-related
involution on thymus structure and function can be substantially
reversed by restoring FOXN1 function, establishing that loss of
FOXN1 expression is the principal cause of these components
of thymic involution. They further provide insight into the
mechanisms by which FOXN1 mediates thymus regeneration.
Our findings contrast with the outcome of provoking thymus
regeneration via sex-steroid ablation, which a recent study has
shown results in transient generation of an enlarged, but
phenotypically old thymus with no change in TRA expression
or medullary complexity, and no upregulation of key regulatory
and functional genes compared with aged controls (Griffith
et al., 2012). In addition, most of the genes involved in the Wnt
signaling pathway that were examined herein were downregulated
during age-related thymic involution, in agreement with a
previous study (Griffith et al., 2012). These genes were restored
to young expression levels upon upregulation of FOXN1 activity
in aged TECs, whereas their expression is not restored following
sex steroid ablation-mediated rebound (Griffith et al., 2012).
In vivo manipulation of FOXN1 expression, which not only
enlarges the aged thymus but also restores its function, therefore
presents a promising alternative strategy for clinical thymus
Fig. 5. Induction of FOXN1 improves thymic output in aged thymi. (A) Splenic cell preparations from tamoxifen-treated 12-month-old mice of the
genotypes shown, after gating on CD3+ cells. Naive T cells are CD62L+CD44lo. (B) Average proportions of CD4+ and CD8+ naive T cells in tamoxifen-treated
12- and 24-month-old mice of the genotypes shown (12 months, n=6; 24 months, n=3). (C) Splenic cell preparations from tamoxifen-treated 24-month-old
mice of the genotypes shown, after gating on CD3+CD4+ cells. Recent thymic emigrants (RTEs) are CD62L+CD45RBint. (D) Average proportions of RTEs in
tamoxifen-treated 12- and 24-month-old mice (12 months, Cre/+ n=4, Cre/+;R26Foxn1ER n=6; 24 months, Cre/+ n=6, Cre/+;R26Foxn1ER n=8). (E) Number
of T cell receptor excision circles (TRECs) in naive splenic T cells (CD62L+CD45RB+) from tamoxifen-treated 24-month-old mice (n=6). Black bars, Cre/+;
R26Foxn1ER; white bars, Cre/+ controls, throughout. mo, month. Error bars, s.d.
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regeneration – for instance by small molecule manipulation of
signaling pathways that regulate FOXN1 expression or directly
augment FOXN1 function.
FOXN1 is a powerful regulator of TEC differentiation (Blackburn
et al., 1996;Nehls et al., 1996;Chen et al., 2009;Nowell et al., 2011), is
required throughout TEC development from exit from the earliest
progenitor TEC state to terminal differentiation in both cTEC and
mTEC sub-lineages (Nowell et al., 2011), and has also been implicated
as a regulator of proliferation of fetal TECs (Itoi et al., 2001). In the
context of our experimental model, however, upregulation of FOXN1
did not drive all TECs in the aged thymus to terminal differentiation,
but rather caused a sustained increase in the size of both progenitor and
terminally differentiatedTECcompartments, driven byproliferationof
progenitor cells. This increased proliferation was accompanied by
upregulation of genes that promote cell cycle progression (cyclin D1,
ΔNp63, FgfR2IIIb) and that are required in TECs to promote specific
aspects of T cell development (Dll4,Kitl,Ccl25,Cxcl12,Cd40,Cd80,
Ctsl, Pax1). These data suggest a mechanistic basis for cell cycle
promotion by FOXN1, and indicate that factors in addition to FOXN1
must limit the onset of terminal differentiation in progenitor TECs.
They further establish, to our knowledge for the first time, that cyclin
D1 and ΔNp63 are direct or indirect targets of FOXN1. In conjunction
with a recent report demonstrating that the retinoblastoma family of
proteins can negatively regulate Foxn1 expression in TECs (Garfin
et al., 2013), they thus suggest a complex interplay between FOXN1
expression and cell cycle regulation.
Recently, Sun and colleagues reported that delivery of a FOXN1-
expression plasmid to the aged thymus by intrathymic injection
resulted in increased thymus size. However, as cellular composition,
architecture and function of the thymus were not examined, that study
was not informative regarding the effect of FOXN1 upregulation on
hallmarks of thymic involution, including altered TEC phenotype
and function (Sun et al., 2010). The importance of evaluating these
parameters is highlighted by the findings of Griffiths and colleagues,
discussed above, that the degenerative changes characteristic of age-
associated thymic involution persist despite increased thymic size
during castration-induced thymic rebound (Griffith et al., 2012). In a
separate study, Zook and colleagues reported that overexpression of
FOXN1 from the human keratin 14 (hK14; KRT14 – Human Gene
Nomenclature Database) promoter, which can drive broad expression
in fetal and postnatal TECs including cTECs (Laufer et al., 1996),
delays but does not prevent the onset of age-related thymus
involution (Zook et al., 2011). As thymic involution still occurred
in the presence of FOXN1 overexpression in this model (Zook et al.,
2011), these data suggested that upregulation of FOXN1 should not
be sufficient to regenerate the age-related thymus. In our experiments,
increased FOXN1 expression restored thymic architecture and
function, despite the fact that involution was fully established
before FOXN1 function was upregulated. Our data thus demonstrate
unequivocally that FOXN1 upregulation is sufficient to reverse the
crucial hallmarks of age-related thymic involution, based on all
parameters commonly used to measure thymus structure and
function. The reversibility of these hallmark changes indicates that
the involuted state induced in the thymus by ageing is not locked, for
instance by epigenetic or other mechanisms that result in permanent
loss of key functions, even once fully established. Our data thus
suggest that in the ageing and aged thymus, FOXN1 or its upstream
regulators must be continuously repressed by an active mechanism in
order to suppress FOXN1-mediated regeneration.
Since thediscoveryof inducedpluripotent stemcells (Takahashi and
Yamanaka, 2006), interest has increased in the capacity of a single or a
few transcription factors to program/reprogram cell fate – for instance,
via direct conversion of cell fates or by directing differentiation of
embryonic stem cells into defined cell types (Weintraub et al., 1989;
Seguin et al., 2008; Zhou et al., 2008; Graf and Enver, 2009; Antonica
et al., 2012).Our findings demonstrate that in the aged thymusFOXN1
is sufficient to promote proliferation of progenitor TECs and
differentiation of these cells into fully functional thymic epithelium,
extending this approach to the important goal of whole organ
regeneration in vivo. As discussed, our data show that upregulating
FOXN1 function leads to upregulation of key genes required for TEC
proliferation and function.An important emergingquestion is therefore
whether FOXN1 regulates this diverse set of targets via classical
transactivation, or functions either additionally or alternatively as a
‘pioneer factor’, as recently demonstrated for FoxA proteins (Cirillo
et al., 2002; Zaret and Carroll, 2011).
Collectively, the data presented herein have identified both the
cell type and the gene required for thymus regeneration. These
findings highlight FOXN1 as a specific target for strategies aiming
to achieve thymus regeneration in patients, underlining the need to
understand both its transcriptional regulation and downstream
targets. Finally, by establishing that modulation of a single
transcription factor is sufficient to instigate regeneration of an
entire organ, our findings provide a provocative paradigm that may
be of broad impact for regenerative biology strategies.
MATERIALS AND METHODS
Ethics statement
All animal work was conducted according to UK Home Office guidelines,
as established in the Animals (Scientific Procedures) Act 1986.
Mice
Rosa26CAG-STOP-Foxn1ERT2-IRES-GFP/+ (R26Foxn1ER) mice were backcrossed
onto C57BL/6 for at least three generations then maintained via intercrossing.
Foxn1Cre/+ mice (Gordon et al., 2007) were maintained as homozygotes and
crossed with Rosa26CAG-STOP-Foxn1ERT2-IRES-GFP/+ mice as described to
generate Foxn1Cre/+;Rosa26CAG-Foxn1ERT2-IRES-GFP/+ (Cre/+;R26Foxn1ER
mice). Littermate controls were used in each experiment. For timed
matings, noon of the day of the vaginal plug was taken as E0.5.
Generation of the Foxn1ERT2 targeting vector
A construct containing the targeting cassette (Fig. 1A; supplementary
material Fig. S1A) was generated by standard molecular biology techniques
(Nowell et al., 2011) and verified by sequencing. Conventional subcloning
was used for all cloning steps.
Southern blotting
Genomic DNA was processed for Southern blotting as described (Morris
et al., 2006; Nowell et al., 2011).
Gene targeting and blastocyst injection
Mouse sv129/ola ES cells (line E14tg2a) were electroporated with
linearized targeting vector (supplementary material Fig. S1A) and grown
under Geneticin selection. Correctly targeted clones were identified by
Southern analysis (supplementary material Fig. S1B), expanded and
injected into C57BL/6 blastocysts to generate chimeric mice. Germ-line
transmission was confirmed for two independently targeted cell clones
(supplementary material Fig. S1B); the resulting mouse line was designated
ROSA26CAG-STOP-Foxn1ERT2-IRES-GFP (called R26Foxn1ER herein). The
neomycin resistance cassette was removed by crossing of founder
R26Foxn1ER mice with Tg(CAG-FLPe) mice (Wallace et al., 2007) and
confirmed by Southern analysis (supplementary material Fig. S1C).
Transient transfection
A luciferase reporter cell system (Janes et al., 2004) containing thewild-type
and mutated minimal FOXN1 response elements (Schlake et al., 1997) was
transiently transfected with empty, CAG-Foxn1 and CAG-Foxn1ERT2
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vectors using Lipofectamine 2000 (Invitrogen). Cells were cultured for 48 h
with or without 4-hydroxytamoxifen (1 μM, Sigma), then assayed using a
Luciferase Assay System (Promega) and analyzed on a Mediators PhL
Luminometer (ImmTech).
Tamoxifen treatment
Mice were treated with a single intraperitoneal (IP) injection of tamoxifen
(Sigma) prepared in ethanol and diluted appropriately in Cremophor
(Sigma)/PBS. For regeneration experiments, mice were treated with a single
3 mg IP injection of tamoxifen and then with tamoxifen citrate salt (Sigma)
in the drinking water (0.05 mg/ml) for one month.
Antibodies
The antibodies used for IHC and flow cytometry are listed in supplementary
material Table S1.
Flow cytometry
Analysis
Mouse fetal TECs were processed for flow cytometric analysis as described
(Bennett et al., 2002; Nowell et al., 2011); adult TECs were enzymatically
digested to single cell suspensions as described (Gray et al., 2008) and
processed for cytometric analysis without further enrichment. Naive T cells
(CD3+CD62L+CD44lo) (Budd et al., 1987) and RTEs (CD3+CD4+CD62L+
CD45RBint) (Boursalian et al., 2004) were identified among splenocytes as
described. Data were acquired using LSR Fortessa (BD Biosciences) and
analyzed using FlowJo software (Tree Star).
Sorting
For isolation of adult TECs, TECs were enzymatically digested to single cell
suspensions and enriched as described (Gray et al., 2008). Total TECs
(EpCAM+) or cTECs (EpCAM+Ly51+) or mTECs (EpCAM+Ly51−) were
purified after gating against CD45−Ter119− cells. For isolation of
splenocytes, mouse spleens were mechanically disrupted and red blood
cells were lysed. CD4+ and CD8+ naive splenocytes were purified after
gating on CD3+CD62L+CD45RB+ cells. Cell sorting was performed using a
FACSAriaII (BD Biosciences).
Immunohistochemistry
Adult thymi were processed for IHC as described (Nowell et al., 2011).
Isotype controls (not shown) were included in all experiments. Staining was
analyzed using a Leica AOBS confocal microscope (Leica Microsystems).
The images presented are either single optical sections or projected focus
stacks of serial optical sections. The number of FOXN1+ or AIRE+ TECs
per area was established by analyzing three areas on each of two
non-sequential sections from each of three individual mice. Statistical
analysis was performed on the average number of FOXN1+ or AIRE+ cells
per condition.
RNA isolation
RNA was prepared using an RNAeasy Mini Kit (Qiagen) according to the
manufacturer’s instructions. All samples were DNase treated.
RT-qPCR
cDNA was prepared using the Superscript II First Strand Synthesis Kit
(Invitrogen) with Oligo-dT primers, according to the manufacturer’s
instructions. Relative expression levels were determined using the Roche
Universal Probe Library on the Roche Lightcycler 480 after normalization to
the geometric mean of three housekeeping genes (α-tubulin, HMBS and
TBP) for all experiments except for TRAs, which were normalized to
epithelial V-like antigen (EVA) (DeMonte et al., 2007). Technical triplicates
were run for all samples and no reverse transcriptase and no template
controls were included in all experiments. The primers used for RT-qPCR
are listed in supplementary material Table S2.
TREC
Signal jointTcell receptor delta (TCRD)excisioncircle (sjTREC)quantification
wasbasedon apreviouslydescribedmethod (Sempowski et al., 2002).Genomic
DNAwas isolated from splenocytes by cell lysis (10,000 cells/μl) in 10 mMTris
with 0.05% Tween-20, 0.05% NP-40 and 100 μg/ml Proteinase K.
TREC numbers were quantified on a Roche Lightcycler 480 using the
following primer/probe set: forward primer, 50-CATTGCCTTTGAAC-
CAAGCTGA-30; reverse primer, 50-TTATGCACAGGGTGCAGGTG-30;
probe, FAM-GCAGGTTTTTGTAAAGGTGCTCACTTCT-BHQ (Sigma).
Sampleswere assayed at 25,000 cell equivalents per PCR reaction.ATREC
standard was generated by PCR-cloning a 315-bp fragment, spanning the
TCRD single joint site, from thymocyte genomic DNA into a TOPO-TA
vector (Invitrogen) (primers: 50-TAGGGAAGATGGGCCTCTCTG-30,
50-GTGTGTCCTCAGCCTTGATCCATC-30). Serial dilutions of the TREC
standard (107, 106, 105, 104, 103, 102 and 101 molecules per reaction) were
used to generate a standard curve. To test for equivalent genomic DNA input,
we separately amplified the α-tubulin reference gene.
Western blotting
Nuclear and cytoplasmic protein fractions were prepared using a nuclear
extract kit (Active Motif ) according to the manufacturer’s instructions and
processed for western blotting as described (Depreter et al., 2008; Nowell
et al., 2011).
Statistical analysis
Statistical analysis was performed using the one-way ANOVA test (two
tailed), as appropriate for normally distributed data (normal distribution was
tested using χ2 goodness of fit). The alpha level is taken as 0.05. Errors
shown are standard deviations throughout. Sample sizes of at least n=3 were
used for statistical analyses.
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van den Brink, M. R. M., Alpdogan, Ö. and Boyd, R. L. (2004). Strategies to
enhance T-cell reconstitution in immunocompromised patients. Nat. Rev.
Immunol. 4, 856-867.
Wallace, H. A. C., Marques-Kranc, F., Richardson, M., Luna-Crespo, F.,
Sharpe, J. A., Hughes, J., Wood, W. G., Higgs, D. R. and Smith, A. J. H.
(2007). Manipulating the mouse genome to engineer precise functional syntenic
replacements with human sequence. Cell 128, 197-209.
Wallin, J., Eibel, H., Neubuser, A., Wilting, J., Koseki, H. and Balling, R. (1996).
Pax1 is expressed during development of the thymus epithelium and is required
for normal T-cell maturation. Development 122, 23-30.
Weintraub, H., Tapscott, S. J., Davis, R. L., Thayer, M. J., Adam, M. A.,
Lassar, A. B. and Miller, A. D. (1989). Activation of muscle-specific genes in
pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of
MyoD. Proc. Natl. Acad. Sci. U.S.A. 86, 5434-5438.
Weng, N.-P. (2006). Aging of the immune system: how much can the adaptive
immune system adapt? Immunity 24, 495-499.
Williams, K. M., Lucas, P. J., Bare, C. V., Wang, J., Chu, Y.-W., Tayler, E.,
Kapoor, V. and Gress, R. E. (2008). CCL25 increases thymopoiesis after
androgen withdrawal. Blood 112, 3255-3263.
Zaret, K. S. and Carroll, J. S. (2011). Pioneer transcription factors: establishing
competence for gene expression. Genes Dev. 25, 2227-2241.
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. and Melton, D. A. (2008). In vivo
reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455,
627-632.
Zlotoff, D. A., Sambandam, A., Logan, T. D., Bell, J. J., Schwarz, B. A. and
Bhandoola, A. (2010). CCR7 and CCR9 together recruit hematopoietic
progenitors to the adult thymus. Blood 115, 1897-1905.
Zook, E. C., Krishack, P. A., Zhang, S., Zeleznik-Le, N. J., Firulli, A. B., Witte,
P. L. and Le, P. T. (2011). Overexpression of Foxn1 attenuates age-associated
thymic involution and prevents the expansion of peripheral CD4 memory T cells.
Blood 118, 5723-5731.
1637
RESEARCH ARTICLE Development (2014) 141, 1627-1637 doi:10.1242/dev.103614
D
E
V
E
LO
P
M
E
N
T
